Englewood Hospital First in Northern NJ to Offer New Device for Detection of Precancerous Anal Lesions

June 13, 2024 — Englewood Hospital is the first hospital in northern New Jersey, and one of just 80 in the nation, to offer patients access to the THD® HRStation. This state-of-the-art system is the first and only designed specifically for the detection and treatment of precancerous lesions of the anus.

“This technology allows us to provide immediate and effective treatment, significantly reducing the risk of progression to anal cancer. We are proud to be at the forefront of this innovation, offering our patients the highest standard of care,” said Peter Kaye, MD, colorectal surgeon at Englewood Hospital.

The THD® HRStation supplies high-resolution videos and images of the anal canal to detect dysplasia, abnormal changes in the cells lining the canal that, if left untreated, can progress into anal cancer.

After detecting anal dysplasia, the all-in-one THD® HRStation allows physicians to treat the lesions immediately by cauterizing and thermally closing the blood vessels connected to them, thereby preventing their progression into cancer.

“Screening for anal dysplasia is recommended for individuals at higher risk of anal cancer, including those with HIV or HPV, men who have sex with men (MSM), women with history of cervical, vulvar, or vaginal cancer, transgender individuals (especially transgender women), and individuals with a history of anal warts,” said Dr. Kaye.

“We want to get the word out to everyone but especially those disproportionately affected, including some members of our LGBTQ+ community. By providing this service at the highest level of care, we can make strides in reducing health disparities we see in our diverse communities,” said Anita Ramsetty, MD, director of health equity at Englewood Health.

Screening for anal cancer is not recommended for everyone. Patients should discuss anal cancer screening with their healthcare provider to decide if it’s right for them. If you are considering getting screened, the first step is an anal Pap smear. This simple swab test checks for abnormal cells that could indicate cancer.

To schedule your screening, contact Dr. Kaye’s office of Colon and Rectal Surgery by calling: 201-608-2800.